Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Operations and Comprehensive Loss

v3.24.1.1.u2
Condensed Consolidated Statements of Operations and Comprehensive Loss - USD ($)
$ in Thousands
3 Months Ended
Mar. 31, 2024
Mar. 31, 2023
Income Statement [Abstract]    
Revenues $ 13,471 $ 9,628
Cost of revenues 7,130 5,242
Gross profit 6,341 4,386
Operating expenses:    
General and administrative 5,347 4,207
Sales and marketing 3,563 2,563
Research and development 3,833 2,710
Total operating expenses 12,743 9,480
Loss from operations (6,402) (5,094)
Other income (expenses):    
Interest expense (616) (408)
Interest income 503 162
Other (64) 134
Total other income (expenses), net (177) (112)
Net loss before income taxes (6,579) (5,206)
Income tax expense (benefit) (80) 33
Net loss (6,499) (5,239)
Other comprehensive income (loss):    
Foreign exchange translation adjustment 13 (33)
Total comprehensive loss $ (6,486) $ (5,272)
Net loss per share of common stock, basic (in dollars per share) $ (0.12) $ (0.14)
Net loss per share of common stock, diluted (in dollars per share) $ (0.12) $ (0.14)
Weighted average shares of common stock outstanding, basic (in shares) 53,058,667 37,491,072
Weighted average shares of common stock outstanding, diluted (in shares) 53,058,667 37,491,072